16 results · 30ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

MediAI-OA

FDA 510(k)
FDA Class 2 ·Radiology

Ophthalmic Cannula

FDA UDI
KATENA PRODUCTS, INC.·00841668114032·GIANNETTI MODIFIED J-CANNULA (PK/10)

MOSAIQ Oncology Information System

FDA 510(k)
FDA Class 2 ·Radiology

UNIVERSAL-X (USA) OR /KRYSTAL-X (EUROPE)

FDA 510(k)
FDA Class 2 ·Dental

SYNCHROMED II

FDA Adverse Event
Injury ·MEDTRONIC PUERTO RICO OPERATIONS CO.·Product code LKK·December 5, 2008

DEXTRUS 4136

FDA Adverse Event
Other ·BIOTRONIK SE & CO. KG·Product code NVZ·September 7, 2011

ENDURANT II

FDA Adverse Event
Injury ·MEDTRONIC IRELAND·Product code MIH·July 29, 2013

S-ROM*SLEEVE PRX ZTT, 18D-SML

FDA Adverse Event
Injury ·DEPUY ORTHOPAEDICS INC US·Product code LPH·January 25, 2013

11/13 S-ROM 40MM M SPEC+3

FDA Adverse Event
Injury ·DEPUY ORTHOPAEDICS, INC. 1818910·Product code LPH·January 25, 2013

ALTRX +4 10D 40IDX56OD

FDA Adverse Event
Injury ·DEPUY ORTHOPAEDICS, INC. 1818910·Product code LPH·January 25, 2013

S-ROM M HEAD 36MM +3

FDA Adverse Event
Injury ·DEPUY ORTHOPAEDICS INC US·Product code JDI·January 25, 2013

SROM*STM ST,36+8L NK,18X13X160

FDA Adverse Event
Injury ·DEPUY ORTHOPAEDICS INC US·Product code JDI·January 25, 2013

PINNACLE MTL INS NEUT36IDX56OD

FDA Adverse Event
Injury ·DEPUY ORTHOPAEDICS INC US·Product code KWA·January 25, 2013

PINNACLE MTL INS NEUT36IDX54OD

FDA Adverse Event
Injury ·DEPUY ORTHOPAEDICS, INC. 1818910·Product code KWA·November 28, 2011

S-ROM M HEAD 36MM +3

FDA Adverse Event
Injury ·DEPUY ORTHOPAEDICS, INC. 1818910·Product code JDI·November 28, 2011

Boston Scientific TELIGEN, Implantable Cardiac Defibrillator models E102, E110, the following models are not available in the US: models E103, E111, F102, F103, F110, F111. Sterilized using ethylene oxide. Product Usage: This family of implantable cardioverter defibrillators (ICDs) provide a variety of therapies including: -Ventricular tachyarrhythmia therapy, which is used to treat rhythms associated with sudden cardiac death such as VT and VF; -Bradycardia pacing, including adaptive rate pacing, to detect and treat bradyarrhythmias and to provide cardiac rate support after defibrillation therapy. Boston Scientific implantable cardioverter defibrillators (ICDs) are indicated to provide ventricular antitachycardia pacing (ATP) and ventricular defibrillation for automated treatment of life-threatening ventricular arrhythmias

FDA Enforcement
Class II ·Terminated·Boston Scientific CRM Corp·October 29, 2014